In addition, if the Smn C-T-Neo and/or Smn2B-Neo is used as the Smn mutant background in combination with SMN2 transgenic mice to achieve postnatal survival, new SMA models can potentially be generated with varying degrees of severity. Here, SMN1 is linked to proximal spinal muscular atrophy.